Advertisement

Impact of Cardiac Resynchronization Therapy on Mortality: What Do We Expect from Ongoing Trials?

  • M. Lunati
  • M. Paolucci
  • G. Magenta
  • G. Cattafi
  • R. Vecchi
  • M. Schirru
  • T. Di Camillo
Conference paper

Abstract

Cardiac resynchronization therapy (CRT), a device-based therapy applied in the context of continuing conventional medical treatment for patients with advanced heart failure (HF) and dyssynchronous left-ventricular (LV) contraction, improves cardiac function and quality of life, but its effects on mortality were uncertain until 2003.

Keywords

Cardiac Resynchronization Therapy Advanced Heart Failure Heart Failure Trial Optimal Medical Treatment Conventional Medical Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bradley DJ, Bradley EA, Baughman KL et al (2003) Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized clinical trials. JAMA 289:730–740PubMedCrossRefGoogle Scholar
  2. 2.
    US Food and Drug Administration (2002) Summary of safety and effectiveness: Guidant Contak CD CRT-D system (report). Available at http://www.fda.gov/cdrh/pdf/p010012.html
  3. 3.
    US Food and Drug Administration (2002) Summary of safety and effectiveness: Medtronic Insync ICD Model 7272 (report). Available at http://www.fda.gov/ohrms/dockets/ac/02/briefing/3843b2.htm
  4. 4.
    Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRefGoogle Scholar
  5. 5.
    Cazeau S, Leclerq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880PubMedCrossRefGoogle Scholar
  6. 6.
    Bristow MR, Saxon LA, Boehmer JP et al (2003) Cardiac resynchronization therapy reduces hospitalization and cardiac resynchronization therapy and an implantable defibrillator reduces mortality in chronic heart failure: results of the COMPANION trial. Paper presented at: American College of Cardiology 52nd Annual Scientific Session, 30 March to 2 April 2003, ChicagoGoogle Scholar
  7. 7.
    Young JB, Abraham WT, Smith AL et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced heart failure. The MIRACLE ICD Trial. JAMA 289:2685–2694Google Scholar
  8. 8.
    Bradley DJ (2003) Combining resynchronization and defibrillation therapies for heart failure. JAMA 289:2719–2721PubMedCrossRefGoogle Scholar
  9. 9.
    Cleland JGF, Daubert JC, Erdmann E et al (2001 ) The CARE-HF study: rationale, design and end-points. Eur J Heart Failure 3:481–489CrossRefGoogle Scholar
  10. 10.
    Klein H, Auricchio A, Reek S et al (1999) New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT II. Am J Cardiol 83:91D–97DPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • M. Lunati
    • 1
  • M. Paolucci
    • 1
  • G. Magenta
    • 1
  • G. Cattafi
    • 1
  • R. Vecchi
    • 1
  • M. Schirru
    • 1
  • T. Di Camillo
    • 1
  1. 1.Dipartimento Cardio-Toraco-Vascolare “A. De Gasperis”S.C. ElettrofisiologiaMilanoItaly

Personalised recommendations